Logo image of XOS

XOS INC (XOS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:XOS - US98423B3069 - Common Stock

2.25 USD
+0.11 (+5.14%)
Last: 1/21/2026, 8:00:03 PM
2.1302 USD
-0.12 (-5.32%)
After Hours: 1/21/2026, 8:00:03 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XOS. XOS was compared to 132 industry peers in the Machinery industry. While XOS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, XOS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year XOS has reported negative net income.
  • In the past year XOS had a positive cash flow from operations.
  • In the past 5 years XOS reported 4 times negative net income.
  • In the past 5 years XOS always reported negative operating cash flow.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • With a Return On Assets value of -46.81%, XOS is not doing good in the industry: 87.88% of the companies in the same industry are doing better.
  • XOS's Return On Equity of -111.23% is on the low side compared to the rest of the industry. XOS is outperformed by 85.61% of its industry peers.
Industry RankSector Rank
ROA -46.81%
ROE -111.23%
ROIC N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

  • XOS has a worse Gross Margin (3.15%) than 90.91% of its industry peers.
  • XOS's Gross Margin has declined in the last couple of years.
  • XOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

5

2. Health

2.1 Basic Checks

  • XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XOS has been increased compared to 1 year ago.
  • XOS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, XOS has an improved debt to assets ratio.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • XOS has an Altman-Z score of -4.21. This is a bad value and indicates that XOS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -4.21, XOS is not doing good in the industry: 89.39% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of XOS is 3.47, which is a good value as it means it would take XOS, 3.47 years of fcf income to pay off all of its debts.
  • XOS has a Debt to FCF ratio of 3.47. This is in the better half of the industry: XOS outperforms 65.15% of its industry peers.
  • A Debt/Equity ratio of 0.46 indicates that XOS is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.46, XOS perfoms like the industry average, outperforming 50.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.47
Altman-Z -4.21
ROIC/WACCN/A
WACC9.12%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

  • XOS has a Current Ratio of 2.41. This indicates that XOS is financially healthy and has no problem in meeting its short term obligations.
  • XOS's Current ratio of 2.41 is fine compared to the rest of the industry. XOS outperforms 62.12% of its industry peers.
  • XOS has a Quick Ratio of 1.44. This is a normal value and indicates that XOS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of XOS (1.44) is better than 62.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 1.44
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 13.32% over the past year.
  • The Revenue for XOS has decreased by -16.89% in the past year. This is quite bad
  • The Revenue has been growing by 117.49% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.43%
Revenue 1Y (TTM)-16.89%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%4.5%

3.2 Future

  • Based on estimates for the next years, XOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.94% on average per year.
  • XOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y34.21%
EPS Next 2Y25.74%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue Next Year-13.88%
Revenue Next 2Y4.48%
Revenue Next 3Y6.17%
Revenue Next 5Y5.61%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • XOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XOS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, XOS is valued cheaply inside the industry as 99.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.07
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as XOS's earnings are expected to grow with 18.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.74%
EPS Next 3Y18.94%

More info and screens

0

5. Dividend

5.1 Amount

  • XOS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

XOS INC

NASDAQ:XOS (1/21/2026, 8:00:03 PM)

After market: 2.1302 -0.12 (-5.32%)

2.25

+0.11 (+5.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-13
Earnings (Next)03-26
Inst Owners3.68%
Inst Owner Change-0.01%
Ins Owners33.12%
Ins Owner Change3.92%
Market Cap25.49M
Revenue(TTM)52.25M
Net Income(TTM)-34.55M
Analysts76.67
Price Target6.12 (172%)
Short Float %7.99%
Short Ratio10.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.85%
Min EPS beat(2)15.27%
Max EPS beat(2)16.43%
EPS beat(4)2
Avg EPS beat(4)-19.5%
Min EPS beat(4)-97.18%
Max EPS beat(4)16.43%
EPS beat(8)5
Avg EPS beat(8)0.5%
EPS beat(12)7
Avg EPS beat(12)-0.23%
EPS beat(16)10
Avg EPS beat(16)3.74%
Revenue beat(2)1
Avg Revenue beat(2)16.62%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)38.96%
Revenue beat(4)1
Avg Revenue beat(4)-11.41%
Min Revenue beat(4)-42.74%
Max Revenue beat(4)38.96%
Revenue beat(8)2
Avg Revenue beat(8)-11.81%
Revenue beat(12)3
Avg Revenue beat(12)-15.27%
Revenue beat(16)6
Avg Revenue beat(16)-8.3%
PT rev (1m)-7.69%
PT rev (3m)-7.69%
EPS NQ rev (1m)10.6%
EPS NQ rev (3m)12.34%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)5.63%
Revenue NQ rev (3m)1.24%
Revenue NY rev (1m)-3.72%
Revenue NY rev (3m)-5.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF 4.07
P/OCF 4.07
P/B 0.82
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)-5.27
EYN/A
EPS(NY)-2.56
Fwd EYN/A
FCF(TTM)0.55
FCFY24.57%
OCF(TTM)0.55
OCFY24.57%
SpS4.61
BVpS2.74
TBVpS2.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.81%
ROE -111.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.15%
FCFM 11.99%
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.47
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 1.44
Altman-Z -4.21
F-Score4
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)244.18%
Cap/Depr(5y)306.81%
Cap/Sales(3y)14.15%
Cap/Sales(5y)31.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.43%
EPS Next Y34.21%
EPS Next 2Y25.74%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.89%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%4.5%
Revenue Next Year-13.88%
Revenue Next 2Y4.48%
Revenue Next 3Y6.17%
Revenue Next 5Y5.61%
EBIT growth 1Y12.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.4%
EBIT Next 3Y19.97%
EBIT Next 5Y10.15%
FCF growth 1Y109.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.27%
OCF growth 3YN/A
OCF growth 5YN/A

XOS INC / XOS FAQ

Can you provide the ChartMill fundamental rating for XOS INC?

ChartMill assigns a fundamental rating of 3 / 10 to XOS.


Can you provide the valuation status for XOS INC?

ChartMill assigns a valuation rating of 2 / 10 to XOS INC (XOS). This can be considered as Overvalued.


Can you provide the profitability details for XOS INC?

XOS INC (XOS) has a profitability rating of 0 / 10.